Technology: Artificial Intelligence, Biotechnology, Genetics, Health Care, Pharmaceutical
Industry: Early Drug Development
Headquarters: Hong Kong, Hong Kong Island, Hong Kong
Founded Date: 2014-01-01
Employees Number: 11-50
Funding Status: Late Stage Venture
Investors Number: 27
Total Funding: 306.3
Estimated Revenue: Less than $1M
Last Funding Date: 6/22/2021
Last Funding Type: Series C

Visit Website
ai@insilico.com
http://twitter.com/InsilicoMeds
Register and Claim Ownership